By Joseph Walker

 

Amgen is laying off about 350 U.S. employees of Horizon Therapeutics, the drugmaker that Amgen bought in a $27.8 billion deal that closed earlier this month.

Most of the cuts are for jobs that overlap with existing Amgen jobs, an Amgen spokeswoman tells Dow Jones Newswires.

Amgen is retaining more than 80% of Horizon's U.S. workforce, "reflecting the knowledge and capabilities we need to continue serving patients suffering from rare diseases," the spokeswoman said.

Horizon had a total workforce of 2,190 people as of June 30, according to regulatory filings.

 

Write to Joseph Walker at joseph.walker@wsj.com

(END) Dow Jones Newswires

October 24, 2023 13:05 ET (17:05 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Jan 2024 to Feb 2024 Click Here for more Amgen Charts.
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Feb 2023 to Feb 2024 Click Here for more Amgen Charts.